| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Molecular and Cellular Biology, April 2007, p. 2687-2697, Vol. 27, No. 7
0270-7306/07/$08.00+0 doi:10.1128/MCB.00493-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
,
,¶
Rawan El-Hajj,1,2
Christiane Dohet,1,2
Mikaël Le Clech,1,2,
Pierre-Olivier Couraud,3,4
Philippe Huber,5 and
Danièle Mathieu1,2*
Institut de Génétique Moléculaire de Montpellier CNRS, UMR5535, Montpellier, France,1 Université de Montpellier 2, Montpellier, France,2 Institut Cochin, INSERM/CNRS, Paris, France,3 Université Paris 5, Paris, France,4 CEA, INSERM, Grenoble, France5
Received 21 March 2006/ Returned for modification 20 May 2006/ Accepted 2 January 2007
The basic helix-loop-helix TAL-1/SCL essential for hematopoietic development is also required during vascular development for embryonic angiogenesis. We reported that TAL-1 acts positively on postnatal angiogenesis by stimulating endothelial morphogenesis. Here, we investigated the functional consequences of TAL-1 silencing in human primary endothelial cells. We found that TAL-1 knockdown caused the inhibition of in vitro tubulomorphogenesis, which was associated with a dramatic reduction in vascular endothelial cadherin (VE-cadherin) at intercellular junctions. Consistently, silencing of TAL-1 as well as of its cofactors E47 and LMO2 down-regulated VE-cadherin at both the mRNA and the protein level. Endogenous VE-cadherin transcription could be activated in nonendothelial HEK-293 cells by the sole concomitant ectopic expression of TAL-1, E47, and LMO2. Transient transfections in human primary endothelial cells derived from umbilical vein (HUVECs) demonstrated that VE-cadherin promoter activity was dependent on the integrity of a specialized E-box associated with a GATA motif and was maximal with the coexpression of the different components of the TAL-1 complex. Finally, chromatin immunoprecipitation assays showed that TAL-1 and its cofactors occupied the VE-cadherin promoter in HUVECs. Together, these data identify VE-cadherin as a bona fide target gene of the TAL-1 complex in the endothelial lineage, providing a first clue to TAL-1 function in angiogenesis.
Published ahead of print on 22 January 2007.
Supplemental material for this article may be found at http://mcb.asm.org/.
¶ V. Deleuze and E. Chalhoub contributed equally to the work.
Present address: University of Beirut, Beirut, Lebanon.
Present address: Max Planck Institute for Biochemistry, 82152 Martinsried, Germany.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|